The renal interstitium structurally supports the functional renal units and is involved in almost all renal functions. The degree of renal disfunction strongly correlates to the changes in the tubulointerstitial compartment present in almost all types of glomerular diseases. A phenomenon arising in such an environment is epithelial-mesenchymal transition, i.e. a change of the cell;s epithelial phenotype into a mesenchymal one. Histochemical, immunohistochemical and morphometric analyses were made of 50 renal biopsies with primary glomerulopathies, as well as light-microscopy analyses of semi-thin sections embedded in epoxy resin. Double immunohistochemical stainings with pairs of epithelial and mesenchymal antibodies were also done. The results were analyzed and correlated with the clinical data of the renal function of the patients. The immunohistochemical analyses of the atrophic tubular epithelial cells showed a loss of expression of Cytokeratin and E-cadherin, an enhanced expression of HLA-DRalpha, and a de novo expression of Vimentin and alphaSMA as markers for epithelial-mesenchymal transition. The double immunohistochemical stainings with Cytokeratin/Vimentin and Cytokeratin/alphaSMA showed a simultaneous expression of these antigens in atrophic tubular cells. Their proliferative index was mildly enhanced. Interstitial fibrosis was present in 98% of the analysed biopsies. The analyses show correlations among all the changes in the tubulointerstitial compartment as well as the concentration of creatinine in the serum as a parameter of renal function. The study emphasizes the usefulness of the implementation of histomorphometrical and immunohistochemical techniques as well as ultrastructural and molecular analyses in the process of nephropathological diagnosis.

Download full-text PDF

Source

Publication Analysis

Top Keywords

changes tubulointerstitial
12
tubulointerstitial compartment
12
primary glomerulopathies
8
epithelial-mesenchymal transition
8
double immunohistochemical
8
immunohistochemical stainings
8
renal function
8
atrophic tubular
8
renal
7
immunohistochemical
5

Similar Publications

Proteomics analysis reveals age-related proteins in the urine of chronic kidney disease patients.

Front Med (Lausanne)

January 2025

Department of Nephrology and Institute of Nephrology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Sichuan Clinical Research Center for Kidney Diseases, Chengdu, China.

Chronic kidney disease (CKD) is closely linked to the aging process, making the identification of protein biomarkers that reflect aging in specific organs and tissues crucial for a deeper understanding of this phenomenon. This study aimed to identify potential aging-related proteins present in the urine of CKD patients. Utilizing liquid chromatography-tandem mass spectrometry (LC-MS/MS) proteomic analysis, we identified a total of 1,712 proteins in the urine samples from both healthy controls and CKD patients in our discovery cohort.

View Article and Find Full Text PDF

Graphene Quantum Dots as Antifibrotic Therapy for Kidney Disease.

ACS Appl Bio Mater

January 2025

Department of Internal Medicine, College of Medicine, Seoul National University, Seoul 03080, Korea.

Graphene quantum dots (GQDs) have received much attention for their biomedical applications, such as bioimaging and drug delivery. Additionally, they have antioxidant and anti-inflammatory properties. We used GQDs to treat renal fibrosis and confirmed their ability to protect renal cells from excessive oxidative stress in vitro and in vivo.

View Article and Find Full Text PDF

We encountered a family with hereditary renal failure, renal medullary cysts, pancreatic hypoplasia, hypomagnesemia, liver enzyme abnormalities, and diabetes mellitus (DM). We identified a novel heterozygous variant of HNF1B (NM_000458.4:c.

View Article and Find Full Text PDF

Background: Focal segmental glomerulosclerosis (FSGS) and treatment-resistant minimal change disease (TR-MCD) are heterogeneous disorders with subgroups defined by distinct underlying mechanisms of glomerular and tubulointerstitial injury. A non-invasive urinary biomarker profile has been generated to identify patients with intra-kidney tumor necrosis factor (TNF)-activation and to predict response to anti-TNF treatment. We conducted this proof-of-concept, multi-center, open-label clinical trial to test the hypothesis that in patients with FSGS or TR-MCD and evidence of intra-renal TNF activation based on their biomarker profile, short-term treatment with adalimumab would reverse the elevated urinary excretion of MCP-1 and TIMP-1.

View Article and Find Full Text PDF

A 47-year-old woman with a 12-year history of anemia and high C-reactive protein (CRP) levels was admitted to our hospital with worsening fatigue and night sweats. She had high levels of immunoglobulin G (IgG; 4182 mg/dL), IgA (630.6 mg/dL), and CRP (7.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!